Skip to main content

Table 2 Platelet reactivity and HRPR according to TyG index quartiles

From: Triglyceride glucose index influences platelet reactivity in acute ischemic stroke patients

Characteristics

Q1 (< 2.02) (n = 250)

Q2 (2.02–2.27) (n = 251)

Q3 (2.27–2.52) (n = 251)

Q4 (≥2.52) (n = 250)

P Value

MA (mm)

61.8 [57.8–65.2]

62.1 [58.2–65.5]

62.7 [59.2–66.3]

63.1 [59.7–66.5]

0.004

MAADP (mm)

30.9 [18.1–42.5]

31.0 [16.8–41.3]

31.6 [18.6–42.5]

30.0 [18.3–42.2]

0.645

ADP% (%)

58.4 [39.1–81.4]

60.2 [40.1–85.1]

58.2 [35.5–82.3]

61.6 [41.9–86.0]

0.306

AA% (%)

99.0 [87.2–100]

97.4 [83.7–100]

96.2 [77.9–100]

93.0 [70.0–98.9]

< 0.001

Clopidogrel HRPR, n (%)

40 (16.0)

43 (17.1)

54 (21.5)

51 (20.4)

0.338

Aspirin HRPR, n (%)

18 (7.2)

30 (12.0)

37 (14.7)

45 (18.0)

0.003

  1. Data given as n (%) or median [interquartile range]
  2. Abbreviations: TyG index triglyceride glucose index, Q1–Q4 TyG index quartiles, MA maximum amplitude, MAADP ADP-induced platelet-fibrin clot maximum amplitude, ADP% inhibition rate of adenosine diphosphate (ADP), AA% inhibition rate of arachidonic acid (AA), HRPR high residual on-treatment platelet reactivity